🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/03/2006 41,88 42,60 39,90 41,88 -0,29% 6,45% 271.250
21/03/2006 42,00 43,32 41,04 42,00 +2,64% 5,43% 688.350
20/03/2006 38,70 41,04 38,10 40,92 +7,57% 7,60% 348.583
17/03/2006 39,00 39,60 36,18 38,04 -3,06% 8,77% 344.017
16/03/2006 40,80 41,76 39,12 39,24 -5,90% 6,47% 246.150
15/03/2006 42,84 42,84 40,86 41,70 -1,14% 4,62% 158.150
14/03/2006 42,48 43,14 39,72 42,18 +1,01% 8,05% 337.483
13/03/2006 40,50 42,60 39,90 41,76 +8,24% 6,67% 486.617
10/03/2006 36,00 39,12 35,64 38,58 +6,46% 9,67% 397.733
09/03/2006 39,42 40,20 35,58 36,24 -7,36% 11,72% 630.883
08/03/2006 40,98 41,58 38,04 39,12 -5,78% 8,64% 418.533
07/03/2006 43,20 43,38 39,90 41,52 -2,67% 8,06% 232.383
06/03/2006 43,92 44,52 42,66 42,66 -3,13% 4,23% 182.167
03/03/2006 44,04 44,70 42,90 44,04 +1,24% 4,09% 202.900
02/03/2006 44,40 44,70 42,36 43,50 -2,95% 5,27% 457.433
01/03/2006 46,68 46,80 43,86 44,82 -2,35% 6,30% 247.883
28/02/2006 47,94 48,30 45,90 45,90 -2,17% 5,01% 335.233
27/02/2006 46,80 50,34 46,38 46,92 +0,51% 8,46% 750.933
24/02/2006 44,64 47,82 44,28 46,68 +4,57% 7,93% 382.350
23/02/2006 45,30 45,60 43,80 44,64 -0,53% 3,97% 161.817
22/02/2006 45,66 45,66 43,32 44,88 -0,27% 5,12% 140.417
21/02/2006 46,68 46,80 44,40 45,00 -0,66% 5,14% 235.783
17/02/2006 44,10 45,84 43,20 45,30 +2,72% 5,99% 236.967
16/02/2006 44,34 45,00 42,90 44,10 -0,81% 4,74% 157.883
15/02/2006 43,38 45,48 43,20 44,46 +3,64% 5,26% 329.400
14/02/2006 40,02 43,14 39,60 42,90 +7,36% 8,85% 391.083
13/02/2006 43,92 44,04 39,42 39,96 -9,26% 10,52% 674.950
10/02/2006 47,64 48,24 42,06 44,04 -8,14% 12,97% 577.000
09/02/2006 48,18 49,20 47,10 47,94 +2,44% 4,36% 381.167
08/02/2006 49,14 50,16 45,18 46,80 -4,53% 10,13% 477.533